Electronic pill-boxes in the evaluation of antihypertensive treatment compliance: Comparison of once daily versus twice daily regimen

American Journal of Hypertension

Volumn 13, Issue 2, 2000, Pages 184-190

  Andrejak, Michel ^a   Genes, Nathalie ^b   Vaur, Laurent ^b   Poncelet, Pascal ^c   Clerson, Pierre ^d   Carré, Alain ^e  

^a Service de Pharmacologie Clinique   (France)

^b Medical Department   (France)

^c CMC Darcy   (France)

^d Orgametrie   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

ACE inhibitor; Electronic pill box; Pill count; Treatment compliance; Treatment regimen

Indexed keywords

CAPTOPRIL; TRANDOLAPRIL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PILL; PRIORITY JOURNAL;

EID: 0034049459     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00175-2     Document Type: Article

References (25)

1. Sackett D.L., Gibson E.S., Taylor D.W., et al. Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet. 1:1975;1205-1207.
2. Meredith P.A. Therapeutic implications of drug "holidays" Eur Heart J. 17:(suppl A):1996;21-24.
3. Houston M.C. Beta-adrenergic blocker withdrawal syndromes in hypertension and other cardiovascular diseases. Am Heart J. 116:1988;515-522.
4. Psaty J.M., Koepsell T.D., Wagner E.H., et al. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA. 263:1990;1653-1657.
5. Rangno R.E., Langlois S. Comparison of withdrawal phenomena after propanolol, metoprolol and pindolol. Am Heart J. 104:1982;473-478.
6. Weber M.A. Discontinuation syndrome following cessation of treatment with clonidine and other anti-hypertensive agents. J Cardiovasc Pharmacol. 2:(suppl 1):1980;573-589.
7. Pullar T., Kumar S., Tindal H., et al. Time to stop counting the tablets? Clin Pharmacol Ther. 46:1989;163-166.
8. Rudd P., Byyny R.L., Zachary V., et al. Pill count measures of compliance in a drug trial variability and suitability . Am J Hypertens. 1:1988;309-312.
9. Stewart M. The validity of an interview to assess a patient's drug taking. Am J Prev Med. 3:1987;95-100.
10. Kruse W., Weber E. Dynamics of drug regimen compliance its assessment by microprocessor-base monitoring . Eur J Clin Pharmacol. 38:1990;561-565.
11. Mallion J.M., Meilhac B., Tremel F., et al. Use of a microprocessor-equipped tablet box in monitoring compliance with antihypertensive treatment. J Cardiovasc Pharmacol. 19:(suppl 2):1992;S41-S48.
12. Mallion J.M., Dutrey-Dupagne C., Vaur L., et al. Benefits of electronic pill-boxes in evaluating treatment compliance of patients with mild to moderate hypertension. J Hypertens. 14:1996;137-144.
13. Vaur L., Vaisse B., Genès N., et al. Use of electronic pill-boxes to assess risk of poor treatment compliance results of a large scale trial . Am J Hypertens. 12:1999;374-380.
14. Jamieson M.J., Webster J., Witte K., et al. An evaluation of the A & D UA-751 semi-automated cuff-oscillometric sphygmomanometer. J Hypertens. 8:1990;377-381.
15. Detry J.M.R., Black P., De Backer G., et al. The Belgian Collaborative Study Group Patient compliance and therapeutic coverage: comparison of amlodipine and slow release nifedipine in the treatment of hypertension . Eur J Clin Pharmacol. 47:1995;477-481.
16. Rudd P., Ahmed S., Zachary A.S., et al. Improved compliance measures applications in an ambulatory hypertensive trial . Clin Pharmacol Ther. 48:1990;676-685.
17. Sackett D.L., Haynes R.B., Gibson E.S., et al. Patient compliance with antihypertensive regimens. Patients' Council. Health Educ. 1:1978;18-21.
18. Guerrero D., Rudd P., Bryant-Kosling C., et al. Antihypertensive medication-taking. Investigation of a simple regimen. Am J Hypertens. 6:1993;586-592.
19. Leenen F.H.H., Wilson T.W., Bolli P., et al. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care a randomized clinical trial using electronic monitoring . Can J Cardiol. 13:1997;914-920.
20. Cramer J.A., Mattson R.H., Prevey M.L., et al. How often is medication taken as prescribed? A novel assessment technique. JAMA. 261:1979;3273-3277.
21. Eisen S.A., Miller D.K., Woodward R.S., et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 150:1990;1881-1884.
22. Fujii J., Seki A. Compliance and compliance-improving strategies in hypertension the Japanese experience . J Hypertens. 3:(suppl 1):1985;19-22.
23. Waeber B., Erne P., Saxenhofer H., et al. Use of drug with more than a twenty-four-hour duration of action. J Hypertens. 12:(suppl 3):1994;S67-S71.
24. Lee J.Y., Kuseck J.W., Greene P.G., et al. Assessing medication adherence by pill count and electronic monitoring in the African American study of kidney disease and hypertension (AASK) pilot study. Am J Hypertens. 9:1996;719-725.
25. Black D.M., Brand R.J., Greenlick M., et al. Compliance to treatment for hypertension in elderly patients the SHEP pilot study. Systolic Hypertension in the Elderly Program . J Gerontol. 42:1987;552-557.